From transcriptomic to protein level changes in TDP-43 and FUS loss-of-function cell models

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1849, Issue 12, 2015, Pages 1398-1410

  Colombrita, Claudia ^a,b   Onesto, Elisa ^b   Buratti, Emanuele ^c   de la Grange, Pierre ^d   Gumina, Valentina ^b   Baralle, Francisco E ^c   Silani, Vincenzo ^a,b   Ratti, Antonia ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

ALS; Exon Array; FUS; RNA binding protein; Splicing; TDP 43

Indexed keywords

DICER; EMBRYONIC LETHAL VISION LIKE 3 PROTEIN; FUSED IN SARCOMA PROTEIN; HUC PROTEIN; ISOPROTEIN; POLYMERASE DELTA INTERACTING PROTEIN 3; PROTEIN KINASE; RNA; RNA BINDING PROTEIN; SEPTIN; SEPTIN 6; TAR DNA BINDING PROTEIN; TRAF2 AND NCK INTERACTING PROTEIN KINASE; TRANSCRIPTOME; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; FUS PROTEIN, HUMAN; MESSENGER RNA; PROTEOME; RNA PRECURSOR; SMALL INTERFERING RNA; TDP-43 PROTEIN, HUMAN; TUMOR PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOSKELETON; GENE EXPRESSION; GENETIC REGULATION; HUMAN; HUMAN CELL; LOSS OF FUNCTION MUTATION; NERVE CELL DIFFERENTIATION; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEPLETION; PROTEIN FUNCTION; RNA METABOLISM; RNA SPLICING; TRANSCRIPTOMICS; ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; BIOLOGICAL MODEL; COMPARATIVE STUDY; DEFICIENCY; EXON; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOLECULAR GENETICS; MOUSE; NERVE CELL; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; RNA INTERFERENCE; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; TUMOR CELL LINE;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; DNA-BINDING PROTEINS; EXONS; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, INBRED BALB C; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; NEUROBLASTOMA; NEURONS; PROTEIN ISOFORMS; PROTEOME; RNA INTERFERENCE; RNA PRECURSORS; RNA, MESSENGER; RNA, NEOPLASM; RNA, SMALL INTERFERING; RNA-BINDING PROTEIN FUS; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; TRANSCRIPTOME;

EID: 84946429592     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2015.10.015     Document Type: Article

References (53)

1. Guerreiro R., Bras J., Hardy J. SnapShot: genetics of ALS and FTD. Cell 2015, 160:798.
2. Thomas M., Alegre-Abarrategui J., Wade-Martins R. RNA dysfunction and aggrephagy at the centre of an amyotrophic lateral sclerosis/frontotemporal dementia disease continuum. Brain 2013, 136:1345-1360.
3. Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., Oda T. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006, 351:602-611.
4. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., McCluskey L.F., Miller B.L., Masliah E., Mackenzie I.R., Feldman H., Feiden W., Kretzschmar H.A., Trojanowski J.Q., Lee V.M. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314:130-133.
5. Mackenzie I.R., Rademakers R., Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 2010, 9:995-1007.
6. Haass C. Cellular mechanisms of ALS mutations - a loss or a gain of function?. Drug Res. 2013, 63(Suppl. 1):S17. (Stuttg).
7. Baralle M., Buratti E., Baralle F.E. The role of TDP-43 in the pathogenesis of ALS and FTLD. Biochem. Soc. Trans. 2013, 41:1536-1540.
8. Buratti E., Romano M., Baralle F.E. TDP-43 high throughput screening analyses in neurodegeneration: advantages and pitfalls. Mol. Cell. Neurosci. 2013, 56:465-474.
9. Orozco D., Edbauer D. FUS-mediated alternative splicing in the nervous system: consequences for ALS and FTLD. J. Mol. Med. 2013, 91:1343-1354. (Berl).
10. Rogelj B., Easton L.E., Bogu G.K., Stanton L.W., Rot G., Curk T., Zupan B., Sugimoto Y., Modic M., Haberman N., Tollervey J., Fujii R., Takumi T., Shaw C.E., Ule J. Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain. Sci. Rep. 2012, 2:603.
11. Lagier-Tourenne C., Polymenidou M., Hutt K.R., Vu A.Q., Baughn M., Huelga S.C., Clutario K.M., Ling S.C., Liang T.Y., Mazur C., Wancewicz E., Kim A.S., Watt A., Freier S., Hicks G.G., Donohue J.P., Shiue L., Bennett C.F., Ravits J., Cleveland D.W., Yeo G.W. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs. Nat. Neurosci. 2012, 15:1488-1497.
12. D'Ambrogio A., Buratti E., Stuani C., Guarnaccia C., Romano M., Ayala Y.M., Baralle F.E. Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo. Nucleic Acids Res. 2009, 37:4116-4126.
13. de la Grange P., Dutertre M., Martin N., Auboeuf D. FAST DB: a website resource for the study of the expression regulation of human gene products. Nucleic Acids Res. 2005, 33:4276-4284.
14. de la Grange P., Dutertre M., Correa M., Auboeuf D. A new advance in alternative splicing databases: from catalogue to detailed analysis of regulation of expression and function of human alternative splicing variants. BMC Bioinf. 2007, 8:180.
15. Gandoura S., Weiss E., Rautou P.E., Fasseu M., Gustot T., Lemoine F., Hurtado-Nedelec M., Hego C., Vadrot N., Elkrief L., Letteron P., Tellier Z., Pocidalo M.A., Valla D., Lebrec D., Groyer A., Monteiro R.C., de la Grange P., Moreau R. Gene- and exon-expression profiling reveals an extensive LPS-induced response in immune cells in patients with cirrhosis. J. Hepatol. 2013, 58:936-948.
16. Wang E., Aslanzadeh V., Papa F., Zhu H., de la Grange P., Cambi F. Global profiling of alternative splicing events and gene expression regulated by hnRNPH/F. PLoS One 2012, 7.
17. Pawitan Y., Michiels S., Koscielny S., Gusnanto A., Ploner A. False discovery rate, sensitivity and sample size for microarray studies. Bioinformatics 2005, 21:3017-3024.
18. Furney S.J., Pedersen M., Gentien D., Dumont A.G., Rapinat A., Desjardins L., Turajlic S., Piperno-Neumann S., de la Grange P., Roman-Roman S., Stern M.H., Marais R. SF3B1 mutations are associated with alternative splicing in uveal melanoma. Cancer Discov. 2013, 3:1122-1129.
19. O. Papadodima, A. Chatziioannou, M. Patrinou-Georgoula, F.N. Kolisis, V. Pletsa, A. Guialis, HuR-regulated mRNAs associated with nuclear hnRNP A1-RNP complexes, Int. J. Mol. Sci. 14 20256-81.
20. Colombrita C., Onesto E., Megiorni F., Pizzuti A., Baralle F.E., Buratti E., Silani V., Ratti A. TDP-43 and FUS RNA-binding proteins bind distinct sets of cytoplasmic messenger RNAs and differently regulate their post-transcriptional fate in motoneuron-like cells. J. Biol. Chem. 2012, 287:15635-15647.
21. Pagani F., Buratti E., Stuani C., Baralle F.E. Missense, nonsense, and neutral mutations define juxtaposed regulatory elements of splicing in cystic fibrosis transmembrane regulator exon 9. J. Biol. Chem. 2003, 278:26580-26588.
22. Ishigaki S., Masuda A., Fujioka Y., Iguchi Y., Katsuno M., Shibata A., Urano F., Sobue G., Ohno K. Position-dependent FUS-RNA interactions regulate alternative splicing events and transcriptions. Sci. Rep. 2012, 2:529.
23. Nakaya T., Alexiou P., Maragkakis M., Chang A., Mourelatos Z. FUS regulates genes coding for RNA-binding proteins in neurons by binding to their highly conserved introns. RNA 2013, 19:498-509.
24. Sephton C.F., Cenik C., Kucukural A., Dammer E.B., Cenik B., Han Y., Dewey C.M., Roth F.P., Herz J., Peng J., Moore M.J., Yu G. Identification of neuronal RNA targets of TDP-43-containing ribonucleoprotein complexes. J. Biol. Chem. 2011, 286:1204-1215.
25. Fiesel F.C., Voigt A., Weber S.S., Van den Haute C., Waldenmaier A., Gorner K., Walter M., Anderson M.L., Kern J.V., Rasse T.M., Schmidt T., Springer W., Kirchner R., Bonin M., Neumann M., Baekelandt V., Alunni-Fabbroni M., Schulz J.B., Kahle P.J. Knockdown of transactive response DNA-binding protein (TDP-43) downregulates histone deacetylase 6. Embo J. 2010, 29:209-221.
26. Shiga A., Ishihara T., Miyashita A., Kuwabara M., Kato T., Watanabe N., Yamahira A., Kondo C., Yokoseki A., Takahashi M., Kuwano R., Kakita A., Nishizawa M., Takahashi H., Onodera O. Alteration of POLDIP3 splicing associated with loss of function of TDP-43 in tissues affected with ALS. PLoS One 2012, 7.
27. Tollervey J.R., Curk T., Rogelj B., Briese M., Cereda M., Kayikci M., Konig J., Hortobagyi T., Nishimura A.L., Zupunski V., Patani R., Chandran S., Rot G., Zupan B., Shaw C.E., Ule J. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat. Neurosci. 2011, 14:452-458.
28. Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., Baralle F., de Belleroche J., Mitchell J.D., Leigh P.N., Al-Chalabi A., Miller C.C., Nicholson G., Shaw C.E. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008, 319:1668-1672.
29. Budini M., Romano V., Avendano-Vazquez S.E., Bembich S., Buratti E., Baralle F.E. Role of selected mutations in the Q/N rich region of TDP-43 in EGFP-12xQ/N-induced aggregate formation. Brain Res. 2012, 1462:139-150.
30. Moon I.S., Lee H., Walikonis R.S. Septin 6 localizes to microtubules in neuronal dendrites. Cytotechnology 2013, 65:179-186.
31. Liyou N.E., Buller K.M., Tresillian M.J., Elvin C.M., Scott H.L., Dodd P.R., Tannenberg A.E., McManus M.E. Localization of a brain sulfotransferase, SULT4A1, in the human and rat brain: an immunohistochemical study. J. Histochem. Cytochem. 2003, 51:1655-1664.
32. Gregory R.I., Yan K.P., Amuthan G., Chendrimada T., Doratotaj B., Cooch N., Shiekhattar R. The microprocessor complex mediates the genesis of microRNAs. Nature 2004, 432:235-240.
33. Kawahara Y., Mieda-Sato A. TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:3347-3352.
34. Fu C.A., Shen M., Huang B.C., Lasaga J., Payan D.G., Luo Y. TNIK, a novel member of the germinal center kinase family that activates the c-Jun N-terminal kinase pathway and regulates the cytoskeleton. J. Biol. Chem. 1999, 274:30729-30737.
35. Traikov S., Stange C., Wassmer T., Paul-Gilloteaux P., Salamero J., Raposo G., Hoflack B. Septin6 and Septin7 GTP binding proteins regulate AP-3- and ESCRT-dependent multivesicular body biogenesis. PLoS One 2014, 9.
36. Colombrita C., Silani V., Ratti A. ELAV proteins along evolution: back to the nucleus?. Mol. Cell. Neurosci. 2013, 56:447-455.
37. Honda D., Ishigaki S., Iguchi Y., Fujioka Y., Udagawa T., Masuda A., Ohno K., Katsuno M., Sobue G. The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons. FEBS Open Bio 2013, 4:1-10.
38. Kim S.H., Shanware N.P., Bowler M.J., Tibbetts R.S. Amyotrophic lateral sclerosis-associated proteins TDP-43 and FUS/TLS function in a common biochemical complex to co-regulate HDAC6 mRNA. J. Biol. Chem. 2010, 285:34097-34105.
39. Ling S.C., Albuquerque C.P., Han J.S., Lagier-Tourenne C., Tokunaga S., Zhou H., Cleveland D.W. ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:13318-13323.
40. Prudencio M., Jansen-West K.R., Lee W.C., Gendron T.F., Zhang Y.J., Xu Y.F., Gass J., Stuani C., Stetler C., Rademakers R., Dickson D.W., Buratti E., Petrucelli L. Misregulation of human sortilin splicing leads to the generation of a nonfunctional progranulin receptor. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:21510-21515.
41. Robberecht W., Philips T. The changing scene of amyotrophic lateral sclerosis. Nat. Rev. Neurosci. 2013, 14:248-264.
42. Smith B.N., Ticozzi N., Fallini C., Gkazi A.S., Topp S., Kenna K.P., Scotter E.L., Kost J., Keagle P., Miller J.W., Calini D., Vance C., Danielson E.W., Troakes C., Tiloca C., Al-Sarraj S., Lewis E.A., King A., Colombrita C., Pensato V., Castellotti B., de Belleroche J., Baas F., ten Asbroek A.L., Sapp P.C., McKenna-Yasek D., McLaughlin R.L., Polak M., Asress S., Esteban-Perez J., Munoz-Blanco J.L., Simpson M., van Rheenen W., Diekstra F.P., Lauria G., Duga S., Corti S., Cereda C., Corrado L., Soraru G., Morrison K.E., Williams K.L., Nicholson G.A., Blair I.P., Dion P.A., Leblond C.S., Rouleau G.A., Hardiman O., Veldink J.H., van den Berg L.H., Al-Chalabi A., Pall H., Shaw P.J., Turner M.R., Talbot K., Taroni F., Garcia-Redondo A., Wu Z., Glass J.D., Gellera C., Ratti A., Brown R.H., Silani V., Shaw C.E., Landers J.E. Exome-wide rare variant analysis identifies TUBA4A mutations associated with familial ALS. Neuron 2014, 84:324-331.
43. Kawabe H., Neeb A., Dimova K., Young S.M., Takeda M., Katsurabayashi S., Mitkovski M., Malakhova O.A., Zhang D.E., Umikawa M., Kariya K., Goebbels S., Nave K.A., Rosenmund C., Jahn O., Rhee J., Brose N. Regulation of Rap2A by the ubiquitin ligase Nedd4-1 controls neurite development. Neuron 2010, 65:358-372.
44. Coba M.P., Komiyama N.H., Nithianantharajah J., Kopanitsa M.V., Indersmitten T., Skene N.G., Tuck E.J., Fricker D.G., Elsegood K.A., Stanford L.E., Afinowi N.O., Saksida L.M., Bussey T.J., O'Dell T.J., Grant S.G. TNiK is required for postsynaptic and nuclear signaling pathways and cognitive function. J. Neurosci. 2012, 32:13987-13999.
45. Hussain N.K., Hsin H., Huganir R.L., Sheng M. MINK and TNIK differentially act on Rap2-mediated signal transduction to regulate neuronal structure and AMPA receptor function. J. Neurosci. 2010, 30:14786-14794.
46. Brennan M.D., Condra J. Transmission disequilibrium suggests a role for the sulfotransferase-4A1 gene in schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005, 139B:69-72.
47. Potkin S.G., Turner J.A., Guffanti G., Lakatos A., Fallon J.H., Nguyen D.D., Mathalon D., Ford J., Lauriello J., Macciardi F. A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype. Schizophr. Bull. 2009, 35:96-108.
48. Folco E.G., Lee C.S., Dufu K., Yamazaki T., Reed R. The proteins PDIP3 and ZC11A associate with the human TREX complex in an ATP-dependent manner and function in mRNA export. PLoS One 2012, 7.
49. Richardson C.J., Broenstrup M., Fingar D.C., Julich K., Ballif B.A., Gygi S., Blenis J. SKAR is a specific target of S6 kinase 1 in cell growth control. Curr. Biol. 2004, 14:1540-1549.
50. Volonte C., Apolloni S., Parisi C. MicroRNAs: newcomers into the ALS picture. CNS Neurol. Disord. Drug Targets 2015, 14:194-207.
51. Stalekar M., Yin X., Rebolj K., Darovic S., Troakes C., Mayr M., Shaw C.E., Rogelj B. Proteomic analyses reveal that loss of TDP-43 affects RNA processing and intracellular transport. Neuroscience 2015, 293:157-170.
52. Mittal N., Scherrer T., Gerber A.P., Janga S.C. Interplay between posttranscriptional and posttranslational interactions of RNA-binding proteins. J. Mol. Biol. 2011, 409:466-479.
53. Wang X., Schwartz J.C., Cech T.R. Nucleic acid-binding specificity of human FUS protein. Nucleic Acids Res. 2015, 43:7535-7543.